BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31743434)

  • 1. High-dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases.
    Kalra M; Adra N; Hanna N; Abonour R; Einhorn LH
    Cancer; 2020 Mar; 126(6):1202-1207. PubMed ID: 31743434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience.
    Adra N; Abonour R; Althouse SK; Albany C; Hanna NH; Einhorn LH
    J Clin Oncol; 2017 Apr; 35(10):1096-1102. PubMed ID: 27870561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Salvage Therapy of Relapsed/Refractory Germ Cell Tumors: A Single-Center Experience.
    Yildiran Keskin GS; Erturk I; Aykan MB; Acar R; Dumludag A; Topal A; Koseoglu C; Kuzu OF; Ornek E; Karadurmus N
    Oncol Res Treat; 2024; 47(6):262-272. PubMed ID: 38583428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage chemotherapy with high-dose carboplatin plus etoposide and autologous peripheral blood stem cell transplant in male pure choriocarcinoma: a retrospective analysis of 13 cases.
    Papiani G; Einhorn LH
    Bone Marrow Transplant; 2007 Aug; 40(3):235-7. PubMed ID: 17563738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study.
    Baek HJ; Park HJ; Sung KW; Lee SH; Han JW; Koh KN; Im HJ; Kang HJ; Park KD
    J Neurooncol; 2013 Sep; 114(3):329-38. PubMed ID: 23824533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-line high-dose chemotherapy combined with peripheral blood stem cell transplantation for patients with advanced extragonadal germ cell tumors.
    Kumano M; Miyake H; Hara I; Furukawa J; Takenaka A; Fujisawa M
    Int J Urol; 2007 Apr; 14(4):336-8. PubMed ID: 17470166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage therapy with high-dose chemotherapy and peripheral blood stem cell transplant in patients with primary mediastinal nonseminomatous germ cell tumors.
    Suleiman Y; Siddiqui BK; Brames MJ; Abonour R; Einhorn LH
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):161-3. PubMed ID: 22892555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor.
    Takada A; Ii N; Hirayama M; Toyoda H; Matsubara T; Toyomasu Y; Kawamura T; Daimon T; Sakuma H; Nomoto Y
    J Neurosurg Pediatr; 2018 Nov; 23(3):317-324. PubMed ID: 30497152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable hematopoietic recovery after peripheral blood stem cell transplantation in patients receiving high-dose chemotherapy for advanced germ cell tumors.
    Kumano M; Miyake H; Hara I; Furukawa J; Takenaka A; Fujisawa M
    Anticancer Res; 2006; 26(6C):4965-8. PubMed ID: 17214371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
    Fleischhack G; Pöpping K; Hasan C; Utsch B; Jüttner J; Bode U
    Klin Padiatr; 1998; 210(4):248-55. PubMed ID: 9743961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high-dose chemotherapy and peripheral blood stem cell transplantation.
    Agrawal V; Abonour R; Abu Zaid M; Althouse SK; Ashkar R; Albany C; Hanna NH; Einhorn LH; Adra N
    Cancer; 2021 Oct; 127(20):3751-3760. PubMed ID: 34260067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?
    Banna GL; De Giorgi U; Ferrari B; Castagna L; Alloisio M; Marangolo M; Rosti G; Santoro A
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1085-91. PubMed ID: 17084372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study.
    Selle F; Wittnebel S; Biron P; Gravis G; Roubaud G; Bui BN; Delva R; Bay JO; Fléchon A; Geoffrois L; Caty A; Soares DG; de Revel T; Fizazi K; Gligorov J; Micléa JM; Dubot C; Provent S; Temby I; Gaulet M; Horn E; Brindel I; Lotz JP
    Ann Oncol; 2014 Sep; 25(9):1775-1782. PubMed ID: 24894084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.
    Hara I; Miyake H; Yamada Y; Yamanaka K; Furukawa J; Kumano M; Takenaka A; Fujisawa M
    Anticancer Drugs; 2006 Oct; 17(9):1057-66. PubMed ID: 17001179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial germ cell tumors: efficacy of neoadjuvant chemo-radiotherapy without surgical biopsy.
    Takahashi S; Yoshida K; Kawase T
    Keio J Med; 2011; 60(2):56-64. PubMed ID: 21720201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.
    Calaminus G; Frappaz D; Kortmann RD; Krefeld B; Saran F; Pietsch T; Vasiljevic A; Garre ML; Ricardi U; Mann JR; Göbel U; Alapetite C; Murray MJ; Nicholson JC
    Neuro Oncol; 2017 Nov; 19(12):1661-1672. PubMed ID: 29048505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous Stem-Cell Transplantation Outcomes for Relapsed Metastatic Germ-Cell Tumors in the Modern Era.
    Hamid AA; Markt SC; Vicier C; McDermott K; Richardson P; Ho VT; Sweeney CJ
    Clin Genitourin Cancer; 2019 Feb; 17(1):58-64.e1. PubMed ID: 30309761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose chemotherapy with autologous stem cell transplantation for patients with extracranial germ cell tumors - experience of two Brazilian pediatric centers.
    Villela NC; Seber A; Macedo CRPD; Zecchin VG; Guimarães RFDC; Faria TMV; Vidal DO; Jorge GEM; Navarro G; Lopes LF
    Pediatr Hematol Oncol; 2023; 40(6):539-553. PubMed ID: 36940088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose Chemotherapy in Germ Cell Cancer Patients With Brain Metastases: Experience of an Expert Center.
    Delaye M; Benderra MA; Deforceville L; Larghero J; Parquet N; Culine S; Grazziotin-Soares D; Lotz JP
    Am J Clin Oncol; 2021 Aug; 44(8):423-428. PubMed ID: 34081032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
    Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
    Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.